7.3 Tablet Splitting & Crushing Restrictions

Tablet Splitting & Crushing Restrictions

Patients need modified dosage forms all the time — a child who cannot swallow a tablet, a patient fed through a gastrostomy tube, a caregiver asking for “just half a dose.” For an ordinary oral drug, splitting or crushing a tablet is often a routine counter task. For a hazardous oral drug, the exact same physical action changes the entire safety picture, and this is one of the most heavily tested trap areas in the Dispensing Final Dosage Forms domain because it looks like nothing more than routine pharmacy work.

Why Splitting or Crushing Changes the Risk

An intact hazardous drug tablet is contained by its manufacturer coating; simple counting and dispensing — with single chemotherapy-rated gloves as the floor — is generally all that is required, and the task may even qualify for the Assessment of Risk pathway covered earlier in this chapter. Breaking that coating, by splitting, crushing, or otherwise altering the tablet, exposes the drug powder underneath. That powder can become airborne, settle on work surfaces, transfer to gloves and hands, and contaminate any shared equipment — a counting tray, a pill splitter, a spatula — that gets used afterward for an entirely different, non-hazardous prescription. This is precisely why splitting and crushing are classified as manipulation rather than simple counting: the act pulls the task out of Assessment-of-Risk eligibility and into full compounding territory, triggering USP <795>'s nonsterile compounding quality standards plus USP <800>'s containment requirements together — the same interface covered in section 7.1.

Manufacturers sometimes reinforce this risk directly: many hazardous oral drugs are produced as film-coated or otherwise non-scored tablets specifically to discourage splitting, and product labeling may explicitly warn against crushing. Treat a non-scored coating or an explicit “do not crush” labeling note as a reinforcing signal, not the only source of the restriction — the manipulation risk exists for hazardous drugs regardless of what the tablet's physical design happens to look like.

The Core Restriction

USP <800>, together with general nonsterile compounding principles, strongly discourages or prohibits splitting or crushing a hazardous oral dosage form on an open, uncontained surface using shared, non-dedicated equipment. If splitting or crushing a hazardous tablet is clinically unavoidable, it must happen using dedicated equipment reserved only for hazardous drugs, inside a properly contained and ventilated space, with the technician wearing chemotherapy-rated gloves at minimum.

Preferred Alternatives, in Order

1. Ask whether an alternative formulation already exists. Many hazardous drugs are available in more than one strength; a prescriber may be able to prescribe an existing tablet strength instead of asking for a split dose.
2. Route to compounding rather than splitting at the counter. A properly compounded oral suspension, prepared under USP <795> nonsterile compounding standards plus USP <800> containment (dedicated space, dedicated equipment, chemo PPE), is the preferred path when a patient genuinely cannot take the manufactured dosage form.
3. If splitting or crushing truly cannot be avoided, it should happen using dedicated, hazardous-drug-only equipment in a contained and appropriately ventilated space, with chemotherapy-rated gloves worn at minimum, followed by proper cleaning and disposal of contaminated materials and equipment.

Any surface or equipment that does contact a split or crushed hazardous tablet requires the full deactivation/decontamination/cleaning process covered in Chapter 5, not a quick wipe with an alcohol pad.

Realistic Scenario

A caregiver arrives with a new prescription for a hazardous drug tablet, with directions to crush it and mix it into applesauce for a patient with dysphagia. The pharmacy is busy, and the technician on duty is tempted to crush the tablet on the open dispensing counter with the shared pill crusher to keep the queue moving. That shortcut is exactly the error this section is built to catch: crushing is manipulation of a hazardous oral dosage form, not simple dispensing, and doing it on an open, uncontained surface with equipment used for other prescriptions creates both an exposure risk to the technician and a cross-contamination risk for the next patient's medication. The correct response is to decline the open-counter shortcut and route the task appropriately — either using dedicated hazardous-drug-only equipment in a contained space, or referring the request to compounding for a proper liquid preparation instead.